Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Echo initiates clinical study of glucose monitoring system
Echo’s pilot clinical study will enroll 10 patients with diabetes (either Type 1 or Type 2) and will compare data obtained from its Symphony tCGM system with both
Echo’s pilot clinical study will enroll 10 patients with diabetes (either Type 1 or Type 2) and will compare data obtained from its Symphony tCGM system with both
VioQuest’s Xyfid is also intended to relieve and manage the burning and itching associated with various dermatoses including atopic dermatitis, irritant contact dermatitis, radiation dermatitis and other dry
Data from two preclinical studies demonstrated that the three molecules showed statistically superior oral efficacy as well as evidence for improved metabolic and pharmacokinetic profiles compared to an
Before joining Bausch & Lomb, Dr Sheets served as global president and CEO of Hoya Surgical Optics. Previously, Dr Sheets was worldwide vice president of R&D, and chief
The agreement with Boston University encompasses therapeutic applications for SIRT1 modulators in metabolic diseases, including obesity and diabetes, as well as therapeutic modulation of SIRT1 for anti-angiogenic activity
Under the terms of the agreement, Danisco will obtain worldwide exclusive rights to commercialize the product or products developed under this collaboration. In return, Direvo will receive R&D
The subscription by Ipsen for 35.25 million new ordinary shares of GBP0.05 each in the capital of Vernalis, as part of the purchase arrangements, has also been completed.
This approval is conditional upon the company providing some additional information to the FDA. Walter Cuevas, CEO of Interventional Spine, said: “We believe that the PercuDyn System is
If approved, Vasovist will be the first contrast agent approved for marketing in the US for use with magnetic resonance angiography (MRA), a non-invasive modality for imaging blood
In colorectal cancers, EGF-receptors transmit a series of signals through a complex path of intracellular proteins. These signals ultimately instruct the cancer cell to undergo a transcription process